Effect of mucosal immunomodulation with fed cholera toxin on healing of experimental colonic anastomosis

Diseases of the Colon and Rectum

Volumn 45, Issue 6, 2002, Pages 819-825

  Kaplan, Mehmet ^a   Bulent Mentes B ^a   TatlIcIoǧlu, Ertan ^a   Kayhan, Başak ^a   Aybay, Cemalettin ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Anastomosis; Colorectal surgery; Immunomodulators; Mucosal immunity; Repair

Indexed keywords

CHOLERA TOXIN; GAMMA INTERFERON; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; COLON ANASTOMOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH RISK POPULATION; IMMUNE RESPONSE; IMMUNOMODULATION; MUCOSAL IMMUNITY; MUSCLE STRENGTH; NONHUMAN; RAT; RECOMBINANT DNA TECHNOLOGY; SURGICAL RISK; TISSUE INJURY; WOUND HEALING;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANASTOMOSIS, SURGICAL; ANIMALS; BIOMECHANICS; CHOLERA TOXIN; COLON; INTERFERON TYPE II; INTESTINAL MUCOSA; MALE; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 0036272154     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6303-0     Document Type: Article

References (52)

1. Large bowel anastomoses, I: The healing process and sutured anastomoses: A review
2. Anastomotic integrity after operations for large-bowel cancer: A multicentre study
3. Healing of experimental colon anastomosis
4. Healing in the gastrointestinal tract
5. Wound care and wound healing
6. Beneficial effects on intestinal anastomosis of S-2441, a synthetic kallikrein-kinin antagonist: Experimental studies in the rat
7. Neutropenia prevents decrease in strength of rat intestinal anastomosis: Partial effect of oxygen free radical scavengers and allopurinol
8. Prostaglandins in colonic anastomotic healing
9. Influence of pulsed electro-magnetic fields on healing of experimental colonic anastomosis
10. Healing of experimental intestinal anastomoses: Parameters for repair
11. Significance of T-lymphocytes in wound healing
12. Immune aspects of wound repair
13. Lymphocyte function in wound healing and following injury
14. Traumahemorrhage delays wound healing potentially by increasing pro-inflammatory cytokines at the wound site
15. Influence of 5-fluorouracil on colonic healing and expression of transforming growth factor-beta 1
16. Peptide growth factors and wound healing
17. Growth factors and wound healing: Biochemical properties of growth factors and their receptors
18. Growth factors and wound healing
19. The role of growth factors in wound healing
20. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta
21. Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor, type beta
22. Transforming growth factor-β improves healing of radiation-impaired wounds
23. Transforming growth factor βs and wound healing
24. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: Antagonism by IFN-alpha and IFN-gamma in vitro and in vivo
25. Systemic administration of interferon-gamma impairs wound healing
26. Oral tolerance: Mechanisms and therapeutic applications
27. Manipulation of Th responses by oral tolerance
28. Helper Thl and Th2 cell responses following mucosal or systemic immunization with cholera toxin
29. The mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4
30. Cholera toxin B subunit induce IgA switching through the action of TGF-beta 1
31. Bacterial toxins as mucosal adjuvants
32. Immune responses to fed protein antigens in mice, 3: Systemic tolerance or priming is related to age at which antigen is first encountered
33. Route and type of nutrition influence Ig-A-mediating intestinal cytokines
34. An oral B subunit: Whole cell vaccine against cholera
35. Safety and immunogenicity of an oral recombinant cholera B sub-unit-whole cell vaccine in Swedish volunteers
36. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children
37. Diminished nitric oxide production following administration of transforming growth factor-beta1 using a noninflammatory wound repair model
38. Control of nitric oxide production by transforming growth factor-beta1: Mechanistic insights and potential relevance to human disease
39. Differential regulation of macrophage arginine metabolism: A proposed role in wound healing
40. The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model
41. Inhibitory effects of tumor necrosis factor-alpha and interferon-gamma on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8)
42. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma
43. Interleukin-6 activity in wounds
44. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis
45. The biology of interleukin 6
46. Wound healing of intestinal anastomosis after digestive surgery under septic conditions: Participation of local interleukin-6 expression
47. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor β
48. Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice
49. Selective activation of Th1- and Th2-like cells in vivo: Response to human collagen IV
50. Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter double-blind placebo controlled trial
51. + T-cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production
52. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems